Symptoms of Mental Health Disorders in Critical Care Physicians Facing the Second COVID-19 Wave: A Cross-Sectional Study.


Journal

Chest
ISSN: 1931-3543
Titre abrégé: Chest
Pays: United States
ID NLM: 0231335

Informations de publication

Date de publication:
09 2021
Historique:
received: 20 02 2021
revised: 13 04 2021
accepted: 04 05 2021
pubmed: 24 5 2021
medline: 14 9 2021
entrez: 23 5 2021
Statut: ppublish

Résumé

Working in the ICU during the first COVID-19 wave was associated with high levels of mental health disorders. What are the mental health symptoms in health care providers (HCPs) facing the second wave? A cross-sectional study (October 30-December 1, 2020) was conducted in 16 ICUs during the second wave in France. HCPs completed the Hospital Anxiety and Depression Scale, the Impact of Event Scale-Revised (for post-traumatic stress disorder), and the Maslach Burnout Inventory. Of 1,203 HCPs, 845 responded (70%) (66% nursing staff, 32% medical staff, 2% other professionals); 487 (57.6%) had treated more than 10 new patients with COVID-19 in the previous week. Insomnia affected 320 (37.9%), and 7.7% were taking a psychotropic drug daily. Symptoms of anxiety, depression, post-traumatic stress disorder, and burnout were reported in 60.0% (95% CI, 56.6%-63.3%), 36.1% (95% CI, 32.9%-39.5%), 28.4% (95% CI, 25.4%-31.6%), and 45.1% (95% CI, 41.7%-48.5%) of respondents, respectively. Independent predictors of such symptoms included respondent characteristics (sex, profession, experience, personality traits), work organization (ability to rest and to care for family), and self-perceptions (fear of becoming infected or of infecting family and friends, feeling pressure related to the surge, intention to leave the ICU, lassitude, working conditions, feeling they had a high-risk profession, and "missing the clapping"). The number of patients with COVID-19 treated in the first wave or over the last week was not associated with symptoms of mental health disorders. The prevalence of symptoms of mental health disorders is high in ICU HCPs managing the second COVID-19 surge. The highest tiers of hospital management urgently need to provide psychological support, peer-support groups, and a communication structure that ensure the well-being of HCPs.

Sections du résumé

BACKGROUND
Working in the ICU during the first COVID-19 wave was associated with high levels of mental health disorders.
RESEARCH QUESTION
What are the mental health symptoms in health care providers (HCPs) facing the second wave?
STUDY DESIGN AND METHODS
A cross-sectional study (October 30-December 1, 2020) was conducted in 16 ICUs during the second wave in France. HCPs completed the Hospital Anxiety and Depression Scale, the Impact of Event Scale-Revised (for post-traumatic stress disorder), and the Maslach Burnout Inventory.
RESULTS
Of 1,203 HCPs, 845 responded (70%) (66% nursing staff, 32% medical staff, 2% other professionals); 487 (57.6%) had treated more than 10 new patients with COVID-19 in the previous week. Insomnia affected 320 (37.9%), and 7.7% were taking a psychotropic drug daily. Symptoms of anxiety, depression, post-traumatic stress disorder, and burnout were reported in 60.0% (95% CI, 56.6%-63.3%), 36.1% (95% CI, 32.9%-39.5%), 28.4% (95% CI, 25.4%-31.6%), and 45.1% (95% CI, 41.7%-48.5%) of respondents, respectively. Independent predictors of such symptoms included respondent characteristics (sex, profession, experience, personality traits), work organization (ability to rest and to care for family), and self-perceptions (fear of becoming infected or of infecting family and friends, feeling pressure related to the surge, intention to leave the ICU, lassitude, working conditions, feeling they had a high-risk profession, and "missing the clapping"). The number of patients with COVID-19 treated in the first wave or over the last week was not associated with symptoms of mental health disorders.
INTERPRETATION
The prevalence of symptoms of mental health disorders is high in ICU HCPs managing the second COVID-19 surge. The highest tiers of hospital management urgently need to provide psychological support, peer-support groups, and a communication structure that ensure the well-being of HCPs.

Identifiants

pubmed: 34023323
pii: S0012-3692(21)00950-8
doi: 10.1016/j.chest.2021.05.023
pmc: PMC8137352
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

944-955

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021. Published by Elsevier Inc.

Références

BMJ Qual Saf. 2020 Dec;29(12):1050-1052
pubmed: 32900854
J Affect Disord. 2018 Jul;234:67-73
pubmed: 29522946
Am J Respir Crit Care Med. 2011 Nov 15;184(10):1140-6
pubmed: 21852543
Medicina (Kaunas). 2020 Dec 09;56(12):
pubmed: 33317190
JAMA. 2020 Jun 2;323(21):2133-2134
pubmed: 32259193
Am J Respir Crit Care Med. 2007 Apr 1;175(7):698-704
pubmed: 17110646
Int J Public Health. 2020 Sep;65(7):1205-1216
pubmed: 32888048
Ann Intensive Care. 2020 Aug 8;10(1):110
pubmed: 32770449
Am J Respir Crit Care Med. 2007 Apr 1;175(7):686-92
pubmed: 17234905
Asian J Psychiatr. 2020 Dec;54:102384
pubmed: 33271693
Am J Respir Crit Care Med. 2020 Nov 15;202(10):1388-1398
pubmed: 32866409
Crit Care Med. 2001 Oct;29(10):1893-7
pubmed: 11588447
Chest. 2021 Feb;159(2):619-633
pubmed: 32926870
J Affect Disord. 2021 Feb 15;281:91-98
pubmed: 33310451
Front Psychol. 2020 Nov 09;11:581314
pubmed: 33240172
JAMA Surg. 2020 Jun 1;155(6):480-485
pubmed: 32236512
J Clin Med. 2020 Oct 19;9(10):
pubmed: 33086558
Psychiatry Res. 2020 Aug;290:113172
pubmed: 32512357
PLoS One. 2020 Dec 15;15(12):e0244052
pubmed: 33320910
Aust N Z J Psychiatry. 2007 Aug;41(8):637-48
pubmed: 17620160
Brain Behav Immun. 2020 Aug;88:901-907
pubmed: 32437915
J Clin Sleep Med. 2021 Apr 1;17(4):749-755
pubmed: 33226333
Acta Psychiatr Scand. 1983 Jun;67(6):361-70
pubmed: 6880820
Int J Environ Res Public Health. 2020 Jun 15;17(12):
pubmed: 32549273
Psychiatry Res. 2020 Aug;290:113129
pubmed: 32485487
Front Psychol. 2020 Aug 11;11:1960
pubmed: 32849149
JAMA Netw Open. 2020 Mar 2;3(3):e203976
pubmed: 32202646
Curr Psychiatry Rep. 2016 Nov;18(11):104
pubmed: 27739026

Auteurs

Elie Azoulay (E)

Medical Intensive Care Unit, AP-HP, Saint Louis University Hospital, Paris, France. Electronic address: elie.azoulay@aphp.fr.

Frédéric Pochard (F)

Medical Intensive Care Unit, AP-HP, Saint Louis University Hospital, Paris, France.

Jean Reignier (J)

Medical Intensive Care Unit, University Hospital Center, Nantes, France.

Laurent Argaud (L)

Medical Intensive Care Department, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France.

Fabrice Bruneel (F)

Intensive Care Unit, André Mignot Hospital, Le Chesnay, France.

Pascale Courbon (P)

Medical Intensive Care Unit, Cochin University Hospital, AP-HP, Centre-Université de Paris, Paris, France.

Alain Cariou (A)

Medical Intensive Care Unit, Cochin University Hospital, AP-HP, Centre-Université de Paris, Paris, France.

Kada Klouche (K)

Department of Intensive Care Medicine, Lapeyronie Hospital, Montpellier, France.

Vincent Labbé (V)

Medical Intensive Care Unit, AP-HP, Tenon University Hospital, Paris, France.

François Barbier (F)

Medical Intensive Care Unit, La Source Hospital, Centre Hospitalier Régional d'Orléans, Orléans, France.

Christophe Guitton (C)

Medical Intensive Care Unit, Le Mans Hospital, Le Mans, France.

Alexandre Demoule (A)

AP-HP, Groupe Hospitalier Universitaire AP-HP-Sorbonne Université, Pitié-Salpêtrière site, Service de Pneumologie, Médecine Intensive et Réanimation (Département R3S) and Sorbonne Université, INSERM, UMRS1158 Neurophysiologie Respiratoire Expérimentale et Clinique, Paris, France.

Achille Kouatchet (A)

Medical Intensive Care Unit, Angers Teaching Hospital, Angers, France.

Olivier Guisset (O)

Medical Intensive Care Unit, Saint-André Hospital, Bordeaux, France.

Mercé Jourdain (M)

Centre Hospitalier Universitaire Lille, Department of Intensive Care, Hôpital Roger Salengro, INSERM, Lille University, U1190, Lille, France.

Laurent Papazian (L)

Respiratory and Infectious Diseases ICU, AP-HM Hôpital Nord, Marseille, France.

Guillaume Van Der Meersch (G)

Medical-Surgical Intensive Care Unit, AP-HP, Avicenne University Hospital, Bobigny, France.

Danielle Reuter (D)

Medical-Surgical Intensive Care Unit, Centre Hospitalier Sud Francilien, Corbeil, France.

Virginie Souppart (V)

Medical Intensive Care Unit, AP-HP, Saint Louis University Hospital, Paris, France.

Matthieu Resche-Rigon (M)

Clinical Research Unit, AP-HP, Saint Louis University Hospital, Paris, France.

Michael Darmon (M)

Medical Intensive Care Unit, AP-HP, Saint Louis University Hospital, Paris, France.

Nancy Kentish-Barnes (N)

Medical Intensive Care Unit, AP-HP, Saint Louis University Hospital, Paris, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH